Tag Archives: Agilent

Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Global Blood Therapeutics (NASDAQ: GBT) and La Jolla Pharma (NASDAQ: LJPC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Agilent (A – Research Report), Global Blood Therapeutics (GBT – Research Report) and La Jolla Pharma (LJPC – Research Report). Agilent (A) Needham analyst Stephen

A Director at Agilent (NYSE: A) is Selling Shares

Yesterday, a Director at Agilent (A – Research Report), Heidi Fields, sold shares of A for $283.8K. Following Heidi Fields’ last A Sell transaction on September 13, 2018, the stock climbed by 2.1%. See today’s analyst top recommended stocks >>

Agilent (A) Received its Third Buy in a Row

After Deutsche Bank and Robert W. Baird gave Agilent (NYSE: A) a Buy rating last month, the company received another Buy, this time from Jefferies. Analyst Brandon Couillard reiterated a Buy rating on Agilent yesterday and set a price target

Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A) and Bausch Health Companies Inc (NYSE: BHC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agilent (A – Research Report) and Bausch Health Companies Inc (BHC – Research Report) with bullish sentiments. Agilent (A) In a report

Agilent (A) Receives a Buy from Robert W. Baird

Robert W. Baird analyst Catherine Schulte reiterated a Buy rating on Agilent (A – Research Report) yesterday and set a price target of $82. The company’s shares closed yesterday at $78.56, close to its 52-week high of $78.80. Schulte has

Agilent (A) Gets a Buy Rating from Morgan Stanley

Morgan Stanley analyst Steve Beuchaw maintained a Buy rating on Agilent (A – Research Report) today and set a price target of $89. The company’s shares opened today at $66.25. According to TipRanks.com, Beuchaw is a 4-star analyst with an